Abstract
To the Editor: We write as concerned respiratory physicians to offer our views of the ways in which inhaled β2-adrenergic agonists should be used in the care of patients with asthma in the light of recent reports about their effects on the severity of asthma and the risk of death from asthma (Feb. 20 issue).1 2 3 4 5 There is little evidence that inhaled β-agonists have life-threatening side effects when used to reverse acute attacks of asthma, even when they are used in high doses. There are, however, reports that the regular use of high doses of isoproterenol6 , 7 and fenoterol5 causes…
Original language | English (US) |
---|---|
Pages (from-to) | 354-357 |
Number of pages | 4 |
Journal | New England Journal of Medicine |
Volume | 327 |
Issue number | 5 |
DOIs | |
State | Published - Jul 30 1992 |
ASJC Scopus subject areas
- General Medicine